Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology

Clinical Epigenetics

Volumn 8, Issue 1, 2016, Pages

  Shen Gunther, Jane ^a   Wang, Chiou Miin ^b   Poage, Graham M ^a   Lin, Chun Lin ^b   Perez, Luis ^a   Banks, Nancy A ^a   Huang, Tim Hui Ming ^b  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

DNA methylation; HPV; HPV genotyping; Molecular biomarkers; Molecular diagnostics; Pap smear; Pyrosequencing

Indexed keywords

GENOMIC DNA; VIRUS DNA; ADENYLATE CYCLASE; ADENYLYL CYCLASE 8; CADHERIN; CDH8 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; ZNF582 PROTEIN, HUMAN;

ADCY8 GENE; ADULT; AGED; ARTICLE; CANCER GRADING; CDH8 GENE; CERVICAL CANCER CELL LINE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; FEMALE; GENE AMPLIFICATION; GENETIC SCREENING; GENOTYPE; HUMAN; HUMAN CELL; MARKER GENE; MGMT GENE; NONHUMAN; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; SQUAMOUS INTRAEPITHELIAL LESION OF THE CERVIX; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS GENE; WART VIRUS; ZNF582 GENE; CERVICAL INTRAEPITHELIAL NEOPLASIA; EARLY CANCER DIAGNOSIS; GENETICS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PROCEDURES; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX; TUMOR CELL LINE; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VIROLOGY; YOUNG ADULT;

ADENYLYL CYCLASES; ADULT; CADHERINS; CELL LINE, TUMOR; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; DNA METHYLATION; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; GENOTYPE; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MIDDLE AGED; NEOPLASM GRADING; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; SQUAMOUS INTRAEPITHELIAL LESIONS OF THE CERVIX; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84992051599     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1186/s13148-016-0263-9     Document Type: Article

References (52)

1. Papanicolaou GN, Traut HF. The diagnostic value of vaginal smears in carcinoma of the uterus. Am J Obstet Gynecol. 1941;42:193–206.
2. Carmichael DE, Cameron C. The Pap smear. In: The Pap smear: life of George N. Papanicolaou. Springfield: Charles C. Thomas; 1973. p. 68–83.
3. Organization, World Health. Comprehensive cervical cancer control: a guide to essential practice. 2nd ed. Geneva: WHO; 2014. p. 23–72.
4. Dürst M, Gissmann L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A. 1983;80:3812–5.
5. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Patholology. 1999;189:12–9.
6. Roche Molecular Systems. cobas HPV test-package insert. www.fda.gov. [Online] 2011. www.accessdata.fda.gov/cdrh_docs/pdf10/p100020c.pdf. Accessed 4 Apr 2015.
7. Schiffman M, Clifford G, Buonaguro FM. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infectious Agents and Cancer. 2009;4:8.
8. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans—human papillomaviruses, volume 100B. Geneva: World Health Organization; 2012. p. 255–313.
9. Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer. 2003;3:253–66.
10. Brebi P, Maldonado L, Noordhuis MG, Ili C, Leal P, Garcia P, Brait M, et al. Genome-wide methylation profiling reveals zinc finger protein 516 (ZNF516) and FK-506-binding protein 6 (FKBP6) promoters frequently methylated in cervical neoplasia, associated with HPV status and ethnicity in a Chilean population. Epigenetics. 2014;9:308–17.
11. Huang RL, Chang CC, Su PH, Chen YC, Liao YP, Wang HC, et al. Methylomic analysis identifies frequent DNA methylation of zinc finger protein 582 (ZNF582) in cervical neoplasms. Plos One. 2012;7:e41060.
12. Saavedra KP, Brebi PM, Roa JC. Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix. Clin Epigenetics. 2012;4(1):13.
13. Wentzensen N, Sherman ME, Schiffman M, Wang SS. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol. 2009;112(2):293–9.
14. Hansel A, Steinbach D, Greinke C, Schmitz M, Eiselt J, Scheungraber C, et al. A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive women. PLoS One. 2014;9(3):e91905.
15. Siegel EM, Riggs BM, Delmas AL, Koch A, Hakam A, Brown KD. Quantitative DNA methylation analysis of candidate genes in cervical cancer. PLoS One. 2015;10(3):e0122495.
16. Lin H, Chen TC, Chang TC, Cheng YM, Chen CH, Chu TY, et al. Methylated ZNF582 gene as a marker for triage of women with Pap smear reporting low-grade squamous intraepithelial lesions—a Taiwanese Gynecologic Oncology Group (TGOG) study. Gynecol Oncol. 2014;135:64–8.
17. Lendvai Á, Johannes F, Grimm C, Eijsink JJ, Wardenaar R, Volders HH, et al. Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia. Epigenetics. 2012;7:1268–78.
18. Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;4:323.
19. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signal. 2013;6:pl1.
20. Resnick RM, Cornelissen MT, Wright DK, Eichinger GH, Fox HS, ter Schegget J, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst. 1990;82:1477–84.
21. Forslund O, Antonsson A, Nordin P, Stenquist B, Hansson BG. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol. 1999;80:2437–43.
22. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, et al. Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Micro. 2004;42:3176–84.
23. Shen-Gunther J, Yu X. HPV molecular assays: defining analytical and clinical performance characteristics for cervical cytology specimens. Gynecol Oncol. 2011;123:263–71.
24. Docherty SJ, Davis OS, Haworth CM, Plomin R, Mill J. DNA methylation profiling using bisulfite-based epityping of pooled genomic DNA. Methods. 2010;52:255–8.
25. Farkas SA, Milutin-Gašperov N, Grce M, Nilsson TK. Genome-wide DNA methylation assay reveals novel candidate biomarker genes in cervical cancer. Epigenetics. 2013;8:1213–25.
26. Lechner M, Fenton T, West J, Wilson G, Feber A, Henderson S, et al. Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma. Genome Med. 2013;5:15.
27. Division, Computational Biology and Bioinformatics. Methylation intensity for ADCY8 gene set. The Cancer Methylome System. [Online] 2012. [Cited: Aug 1, 2013] http://cbbiweb.uthscsa.edu/KMethylomes/
28. Long JS, Freese J. Models for binary outcomes: interpretation. In: Regression models for categorical dependent variables using Stata. 3rd ed. College Station: Stata Press; 2014. p. 227–308.
29. Lai HC, Lin YW, Huang TH, Yan P, Huang RL, Wang HC, Liu J, Chan MW, Chu TY, Sun CA, Chang CC, Yu MH. Identification of novel DNA methylation markers in cervical cancer. Int J Cancer. 2008;123(1):161–7.
30. Matlashewski G, Banks L. Papillomaviruses. In: Acheson NH, editor. Fundamental of molecular virology. 2nd ed. Hoboken: John Wiley & Sons; 2011. p. 263–71.
31. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.
32. de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7:453–9.
33. Schmitt J, Depuydt C, Benoy I, Bogers J, Antoin J, Arbyn M, et al. Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grads of cervical abnormalities. J Clin Microbio. 2013;51(5):1458–64.
34. Salazar KL, Zhou HS, Xu J, Person LE, Schwartz MR, Mody DR, Ge Y. Multiple human papillomavirus infections and their impact on the development of high-risk cervical lesions. Acta Cytolo. 2015;59(5):391–8.
35. Chan PK, Zhang C, Park JS, Smith-McCune KK, Palefsky JM, Giovannelli L. Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variations. Int J Cancer. 2013;132:2528–36.
36. Blatt AJ, Kennedy R, Luff RD, Austin RM, Rabin DS. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices. Cancer Cytopathol. 2015;123(5):282–8.
37. Vasiljević N, Scibior-Bentkowska D, Brentnall AR, Cuzick J, Lorincz AT. Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women. Gynecol Oncol. 2014;132:709–14.
38. ZNF582 zinc finger protein 582 [Homo sapiens]. NCBI Gene. www.ncbi.nlm.nih.gov/gene/147948. Accessed 4 Apr 2015.
39. Lupo A, Cesaro E, Montano G, Zurlo D, Izzo P, Costanzo P. KRAB-zinc finger proteins: a repressor family displaying multiple biological functions. Curr Genomics. 2013;14:268–78.
40. Chang CC, Huang RL, Wang HC, Liao YP, Yu MH, Lai HC. High methylation rate of LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582 genes in cervical adenocarcinoma. Int J Gynecol Cancer. 2014;24:201–9.
41. CDH8 cadherin 8, type 2 [Homo sapiens]. NCBI Gene. www.ncbi.nlm.nih.gov/gene/1006. Accessed 4 Apr 2015.
42. van Roy F. Beyond E-cadherin: roles of other cadherin superfamily members in cancer. Nat Rev Cancer. 2014;14:121–34.
43. ADCY8 adenylate cyclase 8 (brain) [Homo sapiens]. NCBI Gene. www.ncbi.nlm.nih.gov/gene/114. Accessed 4 Apr 2015.
44. Warrington NM, Gianino SM, Jackson E, Goldhoff P, Garbow JR, Piwnica-Worms D, et al. Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1. Cancer Res. 2010;70:5717–27.
45. Orchel J, Witek L, Kimsa M, Strzalka-Mrozik B, Kimsa M, Olejek A, et al. Expression patterns of kinin-dependent genes in endometrial cancer. Int J Gynecol Cancer. 2012;22:937–44.
46. Wojdacz TK, Dobrovic A. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res. 2007;35:e41.
47. Campion MJ, Canfell K. Cervical cancer screening and preinvasive disease. In: Berek JS, Hacker NF, editors. Berek & Hacker’s gynecologic oncology. 6th ed. New York: Wolters Kluwer; 2015. p. 242–73.
48. Huang TT, Gonzales CB, Gu F, Hsu YT, Jadhav RR, Wang CM, et al. Epigenetic deregulation of the anaplastic lymphoma kinase gene modulates mesenchymal characteristics of oral squamous cell carcinomas. Carcinogenesis. 2013;34(8):1717–27.
49. Jadhav RR, Ye Z, Huang R-L, Liu J, Hsu P-Y, Huang Y-W, et al. Genome-wide DNA methylation analysis reveals estrogen-mediated epigenetic repression of metallothionein-1 gene cluster in breast cancer. Clinical Epigenetics. 2015;7:13.
50. Hsu YT, Gu F, Huang YW, Liu J, Ruan J, Huang RL, Wang CM, et al. Promoter hypomethylation of EpCAM-regulated bone morphogenetic protein gene family in recurrent endometrial cancer. Clin Cancer Res. 2013;19:6272–85.
51. Ghosh S, Gu F, Wang CM, Lin CL, Liu J, Wang H, et al. Genome-wide DNA methylation profiling reveals parity-associated hypermethylation of FOXA1. Breast Cancer Res Treat. 2014;147:653–9.
52. Wolff EM, Byun HM, Han HF, Sharma S, Nichols PW, Siegmund KD, et al. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet. 2010;22:e1000917.